The effects of iontophoresis and electroporation on transdermal delivery of buprenorphine from solutions and hydrogels

The in‐vitro permeation of buprenorphine across skin was investigated to assess the effects of iontophoresis and electroporation on drug permeation from solutions as well as from hydrogels. Iontophoresis (0.3 mA cm−2) increased the buprenorphine permeation from solution by a factor of 14.27 as compared with passive diffusion; the application of electroporation increased the buprenorphine permeation from solutions by a factor of 8.45. The permeation experiments using cellulose membrane and stratum corneum (SC)‐stripped skin as permeation barriers suggested that the enhancement with iontophoresis was primarily due to strong electrophoretic drift of buprenorphine molecules, whereas the enhancement seen with electroporation was mainly attributed to the creation of transient aqueous pores in the SC layer. Application of high‐voltage pulses followed by iontophoresis resulted in a shorter permeation onset time from both solutions and hydrogels as compared with iontophoresis or electroporation alone. The charge repulsion between buprenorphine and chitosan vehicles as well as the competition effects of counter‐ions for carboxymethylcellulose (CMC)‐based polymers may account for the different permeation rates under electrical field. This study demonstrates the feasibility of using hydrogels for delivery of buprenorphine under the application of iontophoresis or electroporation, separately or together.

[1]  L. Block,et al.  Anionic Gels as Vehicles for Electrically-Modulated Drug Delivery. I. Solvent and Drug Transport Phenomena , 1996, Pharmaceutical Research.

[2]  S. Ramanathan,et al.  The use of chitosan gels as matrices for electrically-modulated drug delivery. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[3]  Jim E. Riviere,et al.  Electrically-Assisted Transdermal Drug Delivery , 1997, Pharmaceutical Research.

[4]  J. Weaver,et al.  Comparison of the effects of short, high-voltage and long, medium-voltage pulses on skin electrical and transport properties. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[5]  K. Sharma,et al.  Transdermal delivery of buprenorphine through cadaver skin. , 1994, Journal of pharmaceutical sciences.

[6]  S. Dinh,et al.  Transdermal iontophoretic delivery of methylphenidate HCl in vitro. , 1999, International journal of pharmaceutics.

[7]  J. Fang,et al.  Evaluation of transdermal iontophoresis of enoxacin from polymer formulations: in vitro skin permeation and in vivo microdialysis using Wistar rat as an animal model. , 1999, International journal of pharmaceutics.

[8]  T. Ghosh,et al.  Iontophoresis and electroporation: comparisons and contrasts. , 1999, International journal of pharmaceutics.

[9]  T. Nagai,et al.  Permeation of diclofenac salts through silicone membrane : a mechanistic study of percutaneous absorption of ionizable drugs , 1994 .

[10]  G. A. Hofmann,et al.  Electrically-assisted transdermal delivery of buprenorphine. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[11]  V. Préat,et al.  Transdermal alniditan delivery by skin electroporation. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[12]  Véronique Préat,et al.  Transdermal Delivery of Fentanyl by Electroporation I. Influence of Electrical Factors , 1996, Pharmaceutical Research.

[13]  V. Préat,et al.  Electrically enhanced transdermal delivery of domperidone , 1997 .

[14]  V. Préat,et al.  Mechanisms of a Phosphorothioate Oligonucleotide Delivery by Skin Electroporation , 1998 .

[15]  H O Ho,et al.  The Influence of Cosolvents on the In‐vitro Percutaneous Penetration of Diclofenac Sodium From a Gel System , 1994, The Journal of pharmacy and pharmacology.

[16]  I. Wilding,et al.  Pharmacokinetic evaluation of transdermal buprenorphine in man , 1996 .

[17]  M. Roberts,et al.  Solute molecular size and transdermal iontophoresis across excised human skin , 1993 .

[18]  M. Prausnitz Do high-voltage pulses cause changes in skin structure? , 1996 .

[19]  O. Y. Hu,et al.  Delivery of nalbuphine and its prodrugs across skin by passive diffusion and iontophoresis. , 2000, Journal of Controlled Release.

[20]  L. Radbruch,et al.  Clinical Pharmacokinetics of Transdermal Opioids , 2000, Clinical pharmacokinetics.

[21]  Samir Mitragotri,et al.  Synergistic Effect of Enhancers for Transdermal Drug Delivery , 2000, Pharmaceutical Research.

[22]  Transdermal Delivery of Fentanyl by Electroporation II. Mechanisms Involved in Drug Transport , 1996, Pharmaceutical Research.